Endocrinology

Top Story

European committee recommends dulaglutide label update to reflect REWIND findings

September 21, 2019
FDA NewsPerspective

FDA approves first oral GLP-1 receptor agonist for diabetes

September 20, 2019
The FDA on Friday approved oral semaglutide, the first noninjectable GLP-1 receptor agonist for the treatment of type 2 diabetes, according to an agency press release…
Meeting News

CONCLUDE: ‘Uncertainties’ complicate hypoglycemia findings comparing insulin degludec vs. glargine

September 20, 2019
Adults with insulin-dependent type 2 diabetes assigned to insulin degludec for up to 88 weeks experienced a greater number of severe or confirmed symptomatic…
Meeting News

SUSTAIN 10: Semaglutide tops liraglutide providing support for changing prescribing patterns

September 20, 2019
Among a cohort of adults with type 2 diabetes already using oral medications, those assigned to add a weekly injection of 1 mg semaglutide vs. 1.2 mg liraglutide…
Feature

When Autoimmune Disease Strikes Thrice: Managing Multiple Autoimmune Syndrome

September 20, 2019
By the time Lilly Stairs was diagnosed with psoriatic arthritis at the age of 19 — following an arduous series of tests and doctor visits — she had already…
More Headlines »
CME ABIM MOC

Ace the Case: A 65-Year-Old Patient with Longstanding History of Type 2 Diabetes (T2DM)

No commercial support for this activity.

This educational activity will use a case study to discuss the use of follow-on insulins in a 65-year-old male with…
More »
Video
Meeting News

VIDEO: Name changes, updated competencies in the works for AADE, diabetes educators

August 11, 2019
More »
Resource Centers
American Association of Diabetes Educators Annual Meeting

American Association of Diabetes Educators Annual Meeting

CME ABIM MOC

Ace the Case: A 35-Year-Old Man With Type 2 Diabetes Mellitus and Obesity

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the management of a 35-year-old man with type 2 diabetes…
More »
Current Issues
View the Current Issue